Cullinan Oncology, Inc.
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small mole…
Biotechnology
US, Cambridge [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Cullinan Oncology, Inc. has no acquisition track records yet.
M&A Deals · History
Cullinan Oncology, Inc. has no acquisition track records yet.